DGAP-News
Bio-Gate AG: Bio-Gate successfully markets antiviral and antibacterial Protective Film Spray for surfaces - Seite 2
The MSGB-Tec Protective Film Spray has been proven to inactivate enveloped viruses. In addition to the current corona virus (SARS-CoV-2), these include SARS-CoV, MERS-CoV and flu viruses. It represents a modern concept for a more sustainable treatment that strengthens the effectiveness of existing cleaning cycles and it is suitable for COVID-19 prevention. The spray also has an antibacterial effect and has an odour-binding technology that immediately reduces unpleasant odours in mass transport vehicles.
The use of Bio-Gate's solutions in public institutions and local public transport is a forward-looking measure to respond to the second wave of increasing COVID-19 infection rates. Especially in public transport, the safety of passengers can be further increased with additional passive hygiene standards. In addition to the use of the spray, Bio-Gate organises regular hygiene monitoring, which is carried out by a certified laboratory from Nuremberg on a random basis in all means of transport or other public facilities.
Thomas Konradt, Director of Business Development at Bio-Gate AG, says: "The MSGB-Tec Protective Film Spray is a registered product, through the use of which our customers achieve a guaranteed high-quality hygiene management in a natural way. Our technology is antiviral, antimicrobial and odour-binding. It also has a lasting effect". Marc Lloret-Grau, CEO, adds: "We are very pleased that we have already convinced the first customers of our solutions. In addition to local and long-distance passenger transport, the Protective Film Spray can also be easily and effectively used in public institutions, schools and cinemas to supplement the existing hygiene strategy in these facilities. In this way, we are making a contribution by providing people in enclosed spaces with the highest possible level of safety during these challenging times and we are enabling a return to normality despite corona".
Contact:
Bio-Gate AG
Neumeyerstr. 28-34
D-90411 Nuremberg, Germany
www.bio-gate.de
North America:
Karl Richter
RFH BioTek Inc.
Tel: 416-407-6120
rfh@rfhBioTek.com
Toronto, Canada
Lesen Sie auch
Gerd Rückel
rikutis consulting
gr@rikutis.de
presse@bio-gate.de
Tel +49 (0) 6172 807309